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Abstract
Induction of heat shock protein expression and the heat shock (stress) response are seen in exercise. This exercise-induced
response is thought protective against cellular stress through the expression of heat shock proteins. The highly inducible heat
shock protein 72 (HSP72) has been shown to be expressed in a number of stress-related conditions, but not investigated in women
with polycystic ovary syndrome (PCOS). Twenty-one women (10 controls, 11 with PCOS) concluded an 8-week supervised,
moderate-intensity exercise programme. Monocytes and lymphocytes were analysed by flow cytometry for HSP72 expression
from blood samples prior to, mid-way and at the completion of the programme. The monocyte HSP72 expression showed an
increase from baseline values through mid-way (p = 0.025), and at the completion of the programme (p = 0.011) only in the
control group, the PCOS group showed no significant change. This pattern was similar for lymphocyte HSP72 expression where
a significant increase was found at the completion of the programme (p = 0.01) only in the control group. The magnitude of
increased HSP72 expression following completion of the programme was linked to baseline values only in the control group. In
conclusion, increased HSP72 expression to exercise over an 8-week period was seen in control but not in PCOS women,
suggesting that there is an impairment of HSP72 expression in response to exercise in these women.
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Introduction
Polycystic ovary syndrome (PCOS) is the most prevalent en-
docrine disorder affecting women of reproductive age (Azziz
et al. 2004), and the prevalence in western populations esti-
mated to be between 6 and 10% depending upon the diagnos-
tic criteria used (Bozdag et al. 2016; Legro et al. 2013). The
condition is characterised by disruption of the menstrual cycle
with oligo- or amenorrhoea, hyperandrogenism often present-
ing with acne, seborrhoea and/or hirsutism, and polycystic
ovaries (Chang et al. 2004; Ehrmann 2005; Moran and
Teede 2009). PCOS is accompanied by a higher incidence of
hypertension, insulin resistance (IR) and lipid profile abnor-
malities, resulting in an adverse cardiovascular profile
(DeUgarte et al. 2005; March et al. 2010; Moran and Teede
2009; Sathyapalan and Atkin 2012; Toulis et al. 2011).
Heat shock proteins (HSPs) are present in most cells,
including endothelial cells, and play an important role in
normal cellular homeostasis and cell protection from dam-
age in response to stress stimuli (Xu 2002). They are the
largest family of transcriptionally regulated chaperone pro-
teins that respond to cellular stress to help repair protein
damage, preventing protein aggregation and degrading dam-
aged proteins (Hooper 2007; Soti et al. 2005). The highly
inducible 72-kDa heat shock protein (HSP72) has been
researched in depth in both normal and stress-related con-
ditions (Chung et al. 2008; Kregel 2002; Peart et al. 2011;
Taylor et al. 2010). Primary roles include protection against
stress-induced apoptosis (Mosser et al. 1997), and acting as
a chaperone facilitating the folding of newly synthesised
proteins, as well as the degradation of unstable proteins
(Bukau and Horwich 1998). HSP72 expression has been
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shown to increase under a variety of conditions, such as
exercise (Fehrenbach et al. 2005; Peart et al. 2011), cellular
acidosis (Liu and Steinacker 2001) and hypoxia (Patel et al.
1995). HSP72 may therefore have a key role in patients
with medical conditions due to their protective nature and
increasing the basal levels of HSP72 has previously been
studied in order to confer cellular protection against subse-
quent bouts of stress in an exercise setting (Madden et al.
2008; McClung et al. 2008; Sandstrom et al. 2008).
It has previously been shown that HSP72 expression in
skeletal muscle was low in type II diabetes and IR patients,
whereby the expression is inversely correlated with IR (Bruce
et al. 2003; Kurucz et al. 2002). McCarty (2006) suggested
that individuals with a low expression of HSP72 may be at
higher risk of IR and subsequent diabetes development
(McCarty 2006), and Chung et al. (2008) demonstrated there
to be a reduced skeletal muscle HSP72 protein expression in
obesity (Chung et al. 2008). Furthermore, women with PCOS
were found to have increased serum HSP72 which was posi-
tively correlated with IR, markers of oxidative stress and in-
flammation (Gao et al. 2013), although a study on rats found
that HSP70 serum expression was lower than a control group
but expression was higher in ovarian tissue (Wu et al. 2019). A
further study showed higher HSP90 expression in ovarian
tissues of women with PCOS (Li et al. 2016).
Exercise itself is a form of physiological stress that
induces an increase in the circulating concentrations of
various stress markers, such as noradrenaline (NA) and
HSP72 (Fleshner et al. 2003; Martin-Cordero et al.
2011). HSP function at the cellular level is to protect
against any stressful conditions. Subacute activation of
HSP results in stress tolerance and cytoprotection against
what would be a lethal exposure to stress-induced molec-
ular damage (Kalmar and Greensmith 2009). The induc-
tion of HSP therefore may have broad therapeutic benefits
in the treatment of various diseases. Importantly, it has
been shown that those small chaperone peptides that are
able to stabilise protein confirmation and facilitate the
removal of mutant proteins can indeed protect against IR
and type II diabetes (Chung et al. 2008). This data has
therefore led to the hypothesis that HSP72 may combat
IR. Chung et al. (2008) also showed that humans with
obesity and IR are associated with a decreased expression
of HSP72 in skeletal muscle. A cyclical model proposed
by Hooper and Hooper (2009) suggested that obesity-
related inflammation promotes IR which contributes to
the observed reduction in HSP expression in type II dia-
betes and that increasing HSP expression could in turn
reverse this process. The aim of this initial pilot study
was to assess the heat shock expression in circulating
monocytes and lymphocytes and to investigate the re-
sponse through an 8-week exercise programme in women
with PCOS and healthy controls.
Subjects and methods
All of the participants recruited for this study were aged
between 18 and 40 years of age and gave informed
consent after ethical approval was obtained (LREC:
10/H1313/44). Premenopausal PCOS women (recruited
from outpatients at the Hull and East Yorkshire
Diabetes, Endocrinology and Metabolism Clinic) were
eligible if they showed characteristics of PCOS as de-
scribed by the Rotterdam consensus (Chang et al. 2004).
All control women had regular menses and no evidence
of clinical or biochemical hyperandrogenism. Any vol-
unteer suffering from an existing medical condition that
was defined as a contraindication to exercise or injury
was excluded from the study. At each initial visit, par-
ticipants were screened via a pre-exercise medical ques-
tionnaire to highlight any contraindications to the test
protocol. Participants with a BMI between 18.5 and
40.0 kg/m2 were deemed eligible for the study.
Inclusion and exclusion criteria are shown in Table 1.
Baseline assessment
A maximal exercise test was required to prescribe the
correct exercise intensity for subsequent sessions. The
test was performed on a Woodway ELG55 motorised
treadmill (Woodway, Weil an rhein, Germany) set at
0.1 % gradient throughout the test, which began at a
speed of 4.5 km h−1 for 3.5 min. Gas collection was
made using an Oxycon Pro Metabolic System (Jaegger,
Hoechberg, Germany) throughout. Participants were
asked to wear a facemask that covered the mouth and
nose, and a rotary flow sensor was placed in the mouth-
piece for gas collection. The Oxycon Pro was calibrated
using a 3 ml Hans Rudolph volume calibrating syringe
(Hans Rudolph model 5530, Kansas, USA). Participants
wore a polar heart rate monitor (Polar Electro, OY,
Finland) to monitor their heart rate (HR) throughout
the testing procedure, and a safety harness was worn
for the test procedure in order to ensure full safety.
Readings of HR and VO2 kg
−1 were manually recorded
each minute. Participants were instructed to provide
maximal effort and persist with the test until they felt
they could no longer continue with exercising, or they
reached 85% of their age predicted maximum heart rate
(using Karvonen’s principle of 220-age). The VO2 data
was 30-s stationary time-averaged, and the highest 30-s
average in the incremental phase was regarded as the
VO2max (Midgley et al. 2009). The 30-s stationary time
average provides a good compromise between removing
noise and maintaining the underlying trend in relatively
rapidly changing VO2 data (Midgley et al. 2009).
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Supervised exercise programme
Following baseline assessment, participants attended 3 exer-
cise sessions per week for 8 weeks. Each session was sched-
uled to last 1 h based on participants’ ability. The programme
used a standard protocol on either a Woodway ELG55
motorised treadmill or a HP Cosmos Pulsar Treadmill.
Participants performed all sessions on the treadmill as closely
as possible to 60% VO2max. VO2 kg
−1 was measured after the
warm-up, which lasted for 5 min at 4.5 km h−1 and for a period
of 10 min. The exercise intensity was altered by changing the
treadmill speed if this value was not within ± 2.5% of the
target oxygen uptake. During exercise session visits, fluid in-
take was permitted ad libitum.
Heart rate (HR) and rate of perceived exertion (RPE)
(Foster et al. 2001) were monitored every 15 min, and if the
subject could not continue, they were able to stop if necessary.
Alternatively, reducing exercise intensity for a period of time
to assist recoverywas also allowed. Each session finishedwith
a 5-min cool down at 4.5 km h−1, and participants completed
the session when HR returned to within 120% of normal
values. The study subjects were asked to continue as per their
own choices with regard to calorie intake throughout the
programme.
Further assessments
Participants repeated the baseline assessment within 72 h at
the mid-way point of the programme (4 weeks). This mid-
point assessment was used to evaluate the prescribed exercise
intensity for the reminder of the programme if the individuals’
fitness showed improvement. After completion of the pro-
gramme, a final assessment was undertaken at a scheduled
visit.
Hsp72 analysis
The expression of intracellular HSP72 was measured by flow
cytometry in both monocytes and lymphocytes using an
established assay method (Sandstrom et al. 2009; Vince
et al. 2010). Whole blood (100 μl) from EDTA tubes was
transferred into a 2 ml red blood cell lysing buffer
(Erythrolyse, AbDSerotec, UK) as a 1:10 dilution in distilled
H2O for 10 min at room temperature. Samples were then cen-
trifuged for 5 min at 300g in order to pellet white blood cells,
and the resultant supernatant discarded. White blood cells
were then washed with 2 ml PBS and centrifuged again at
300g for 5 min. Samples were then washed again with 2 ml
PBS and centrifuged at 300g for 5 min then fixed with 100 μl
of fix solution (Leucoperm Reagent A, AbDSerotec, UK) and
left for 15 min at room temperature. Samples were then
washed as above, and permeabilised by adding 100 μl of
permeabilisation solution (Leucoperm Reagent B,
AbDSerotec, UK). Each sample was then divided into two
50-μl aliquots. Then, 4 μl of either a negative control/FITC
(AbDSerotec, UK) or IgG1 anti-HSP72/FITC antibody (Enzo
Life Sciences, USA) was then added to these aliquots and left
to incubate in the dark for 30 min. Samples were then washed
with 2 ml PBS, centrifuged at 300g for 5 min and then resus-
pended in 300 μl PBS. Samples were analysed using flow
cytometry on a BDFACS Calibur® (BD Biosciences, UK)
running CELLQuest Software (BD Biosciences, UK).
Monocytes and lymphocytes were gated by forward scatter
(FSC; cell size) and side scatter (SSC; cell granularity proper-
ties), and a total of 20,000 events were counted (Fig 1a).
Results were calculated as the ratio of the mean fluorescence
intensity (MFI) gained with the anti-HSP antibody to that
obtained with the isotype-matched negative control (Fig.
1b, c).
Statistical analysis
Statistical analysis was performed using SPSS for Windows
NT, version 19.0 (SPSS Inc., Chicago, IL). Changes in HSP72
(main effects) across condition (PCOS or control) and time
(pre-, mid- and post-exercise programme) were analysed
using linear mixed models. Post hoc tests with Sidak-
adjusted p values were used to locate significant paired
Table 1 Inclusion and exclusion criteria
Condition Inclusion Exclusion
PCOS Aged 18–40, premenopausal women
A BMI between 18.5 and 40.0 kg m−2
PCOS (as defined by Rotterdam consensus, 2003)
Pregnancy/breastfeeding/attempting to conceive
History of CV, renal, hepatic and thyroid disease
History of diabetes mellitus
History of physical disability to exercise
History of allergy to insulin/soy oil/purified egg (intralipid)
Currently on oral antidiabetic medicine improving insulin sensitivity
(such as metmorfin, weight reduction medication, e.g. orlistat, sibutramine)
Family history of sudden death
Regular exercise three times a week for the last 3 months
Controls Same as PCOS arm Identical to PCOS arm with the exception of no history of PCOS
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differences where a significant F ratio was observed. Subject
characteristics were analysed between groups by independent
t tests. Two-tailed statistical significance was accepted at p <
0.05.
Results
Subjects and baseline values
Twenty-five women were recruited onto the study, 10 out of
11 controls (91%), and 11 of 14 women (79%) with PCOS
completed the programme and were included in the analysis.
Baseline characteristics for control and PCOS women are
shown in Table 2. There were significant differences in sys-
tolic blood pressure (SBP), VO2max, waist-hip ratio (WHR)
and waist circumference (WC). There were no significant dif-
ferences in either monocyte or lymphocyte HSP72 expression
at baseline. BMI was higher in the PCOS group but did not
quite reach statistical significance (p = 0.056). Clinical mea-
sures were repeated mid-point and after completion of the
programme (Table 3) which showed a significant increase in
VO2max for both groups.
HSP72 expression through the exercise programme
Flow cytometry gating of the target populations was based on
well-established scatter properties (Fig. 1). The control popu-
lation showed a significant increase (main effect for time) in
monocyte-derived HSP72 from pre- to post-intervention, with
a rise in MFI from 5.10 to 9.23, respectively (p = 0.011), and
also pre- to mid-intervention, 5.10 to 6.98, respectively (p =
0.025, Fig. 2). The PCOS group also showed a rise from pre-
to post-intervention (5.41 to 6.38, respectively), but this was
not enough to see a significant change (p = 0.422).
Lymphocyte HSP72 data followed a similar trend to the
monocyte data as both groups showed a rise in HSP72 at each
subsequent time point (Fig. 3). PCOS women saw a rise in
MFI from 3.67 at rest to a peak of 5.27 post-exercise pro-
gramme, although this was not significant (p = 0.155). The
control women saw a significant rise in MFI from resting
values at 3.51 to 6.03 at post-exercise programme (p = 0.01)
Fig. 1 Typical gating strategy (a)
and heat shock protein 72
expression (grey peak) in
lymphocytes (b) and monocytes
(c) compared to isotype-matched
negative control (black peak) an-
tibody labelling
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but the rise from mid- to post-exercise was not significant
(4.29 to 6.03, respectively, p = 0.083). The magnitude of the
increase in HSP72 expression following the completion of the
exercise programme was linked to baseline values in the con-
trol group in both monocytes (p = 0.030) and lymphocytes (p
= 0.015), but this relationship was not observed in the PCOS
group for either monocytes (p = 0.164) or lymphocytes (p =
0.212). No relationships were observed for HSP72 expression
with BMI, body mass, age or VO2max in either monocytes or
lymphocytes at baseline, after completion of the programme,
or overall.
Discussion
The HSP72 response to an 8-week supervised, moderate-
intensity exercise programme within circulating blood cells
was shown to be impaired in women with PCOS compared
to control women. Themagnitude of increased HSP72 expres-
sion was non-significant in women with PCOS, whereas as
may be expected, an increase over time was observed in con-
trols. Various limitations exist in exercise interventions in
women with PCOS (Harrison et al. 2011). They have gener-
ally been small in sample size and have had a significant drop
out rate as also reported here. The ability to assess the possible
influences of lean, overweight and obese individuals with and
without PCOS was not possible due to the limited number of
participants in each group. This study confirms that moderate
intensity exercise (60% VO2max) could be recommended for
this population.
Incorporating exercise as a treatment for PCOS may be
favourable considering the benefits that exercise has in condi-
tions that are associated with PCOS (Moran et al. 2006).
Lifestyle modification has been endorsed by the Androgen
Excess and PCOS Society as a primary choice in the preven-
tion of CVD (Wild et al., 2010). There are well-established
benefits of exercise and weight loss in women with PCOS on
factors such as reproductive function (Palomba et al., 2008),
and improvements in CVD risk markers such as obesity and
cardiorespiratory fitness (Vigorito et al. 2007). Other studies
have also found improvements in women with PCOS as a
result of moderate-intensity exercise (Palomba et al. 2010;
Thomson et al. 2012), but future work could also investigate
the use of incorporating high-intensity interval training or
Table 2 Baseline characteristics
between control and PCOS
women. Age, body mass, blood
pressure, VO2max, BMI, WHR,
WC and HSP72 are compared at
baseline between the two groups
Variables Control baseline (n = 10) PCOS baseline (n = 11) p value
Age 24.26 ± 6.18 28.00 ± 6.72 0.202
Body mass (kg) 71.04 ± 16.42 85.45 ± 18.91 0.080
SBP (mmHg) 123.00 ± 11.44 132.36 ± 11.47 0.027*
DBP (mmHg) 77.50 ± 9.30 81.82 ± 11.21 0.290
VO2max (ml min
−1 kg−1) 36.26 ± 6.38 26.32 ± 4.63 < 0.001*
BMI (kg m−2) 25.92 ± 5.39 31.15 ± 6.30 0.056
Waist-hip ratio 0.79 ± 0.07 0.86 ± 0.06 0.019*
WC (cm) 83.01 ± 14.20 98.05 ± 16.35 0.033*
Monocyte HSP72 (MFI) 5.10 ± 2.41 5.41 ± 2.14 0.756
Lymphocyte HSP72 (MFI) 3.51 ± 1.24 3.67 ± 1.29 0.308
*Significantly different between groups (p < 0.05). All data represented as mean ± SD
Table 3 Clinical characteristics of the control and PCOS women at baseline, mid and post 8 weeks of aerobic training
Control (n = 10) PCOS (n = 11)
Variables Pre Mid Post Pre Mid Post
Body mass (kg) 71.04 ± 16.42 70.66 ± 16.19 70.11 ± 15.83 85.45 ± 18.91 84.45 ± 19.02* 84.04 ± 19.54*
Systolic blood pressure (mmHg) 123.00 ± 11.44 120.50 ± 10.28 117.50 ± 7.65* 132.36 ± 11.47 128.73 ± 11.03* 124.91 ± 10.40*†
Diastolic blood pressure (mmHg) 77.50 ± 9.30 75.00 ± 6.82 73.10 ± 5.43 81.82 ± 11.21 81.36 ± 12.36 76.64 ± 8.82*†
VO2 max (ml min
−1 kg−1) 36.26 ± 6.38 37.49 ± 6.96 39.21 ± 5.82* 26.32 ± 4.63 26.43 ± 4.09 29.71 ± 5.32*†
BMI (kg m−2) 25.92 ± 5.39 25.78 ± 5.36 25.58 ± 5.18 31.15 ± 6.30 30.79 ± 6.32* 30.69 ± 6.48*
Waist to hip ratio 0.79 ± 0.07 0.78 ± 0.06 0.79 ± 0.07 0.86 ± 0.06 0.85 ± 0.07 0.85 ± 0.06
Waist circumference (cm) 83.01 ± 14.20 82.41 ± 14.19 82.16 ± 14.57 98.05 ± 16.35 96.97 ± 17.90 96.12 ± 14.67†
Data are represented as mean ± SD
*Significantly different compared to pre (p < 0.05)
†Significantly different compared to mid (p < 0.05)
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resistance training into a programme in PCOS women which
has previously shown favourable results (Roessler et al.
2013).
The levels of obesity in both children and adults is increas-
ing in developed countries and directly and indirectly impacts
on healthcare budgets. Obesity is associated with IR, glucose
intolerance and abnormal concentrations of lipids/lipoproteins
which can lead to development of type 2 diabetes (Chung
et al. 2008). PCOS is associated with low-grade inflammation
and heat shock proteins have been studied previously in these
patients, but not in response to an exercise programme.
Studies have shown increased serum HSP, positively correlat-
ed with markers of oxidative stress, inflammation and IR (Gao
et al. 2013). At baseline, in the present study, we observed no
difference in monocyte or lymphocyte expression of HSP72
but did not investigate serum HSP72 levels.
Furthermore, obesity-related inflammation may be a factor
in the impaired HSP72 expression observed here (Hooper &
Hooper 2009), as the PCOS group had a higher bodymass and
BMI, but this was not statistically significant (Table 2). We
showed that at baseline, no difference was observed in HSP72
expression within circulating blood cells between controls and
women with PCOS. It has been proposed that a loss of the heat
shock response disrupts metabolic homeostasis which can
lead to a number of pathologies (Hooper et al. 2014). The
beneficial effects of exercise are linked to the ability of cells
to respond to stress and an impaired stress response has also
been linked to pathogenesis of type 2 diabetes (Hooper et al.
Fig. 2 Levels of monocyte
expressed HSP72 in controls
(grey) and PCOS (white) partici-
pants at pre-, mid- and post-
exercise intervention.
aSignificantly different compared
to pre in control group (p =
0.025). bSignificantly different
compared to pre in control group
(p = 0.011)
Fig. 3 Levels of lymphocyte
expressed HSP72 in controls
(grey) and PCOS (white) in par-
ticipants at pre-, mid- and post-
exercise intervention.
aSignificantly different to pre in
control group (p = 0.01)
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2014). Previously, we have shown in vitro that HSP72 induc-
tion is dependent on both temperature and time (Lovell et al.
2007) and that HSP72 expression in monocytes is linked to
core temperature in human subjects (Sandstrom et al. 2009).
Furthermore, increasing the basal levels of HSP72 has previ-
ously been shown to confer cellular protection against subse-
quent bouts of stress in an exercise setting (Madden et al. 2008;
McClung et al. 2008; Sandstrom et al. 2008) and the increase
in HSP72 reported here was linked to baseline values in the
control group, suggesting that higher baseline values are ben-
eficial in adaptation to stress; however, the PCOS group did
not have the same relationship suggesting an impairment of
HSP72 expression. Both groups exercised at a standardised
60% of VO2max; however, the baseline VO2max was signifi-
cantly different between groups (Table 2), and therefore, the
level of exercise output and intensity may be lower in the
PCOS and not enough to elicit an HSP72 increase. VO2max
also significantly increased in both groups following comple-
tion of the programme (Table 3). A limitation of the study is a
relatively low sample size of 25 in total, and the control pop-
ulation was not matched well in terms of body composition
and VO2max, although there was no significant difference in
HSP72 at baseline between the groups. Whilst heat shock ex-
pression within monocytes is an ideal choice for investigating
the heat shock status (Bachelet et al. 1998) within the circula-
tion, it only offers an insight based on this cell population.
Induction of heat shock proteins may not only act to im-
prove IR (Hooper & Hooper 2009) and overall metabolic
health, but has also been proposed to potentially alleviate mi-
crovascular and macrovascular complications associated with
diabetes (McCarty 2006), although as highlighted here, al-
though the PCOS did show an increase in HSP72 expression,
this was not at the levels seen in the control group. To achieve
higher HSP72 through exercise in women with PCOS may
require a longer programme of exercise as increasing the in-
tensity of the programme above 60% VO2max would not be
suitable for this population and would likely result in an in-
creased drop-out rate.
Conclusion
A supervised exercise programme devised was suitable for
women with PCOS who displayed an impaired HSP72 ex-
pression when compared with controls.
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